Equities research analysts forecast that Walgreens Boots Alliance Inc (NASDAQ:WBA) will report $1.08 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Walgreens Boots Alliance's earnings. The highest EPS estimate is $1.41 and the lowest is $0.97. Walgreens Boots Alliance posted earnings per share of $1.37 during the same quarter last year, which would suggest a negative year-over-year growth rate of 21.2%. The business is expected to announce its next earnings report on Wednesday, January 13th.
According to Zacks, analysts expect that Walgreens Boots Alliance will report full-year earnings of $4.93 per share for the current year, with EPS estimates ranging from $4.76 to $5.77. For the next year, analysts expect that the company will post earnings of $5.27 per share, with EPS estimates ranging from $4.90 to $6.17. Zacks Investment Research's EPS averages are an average based on a survey of research firms that that provide coverage for Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, October 15th. The pharmacy operator reported $1.02 earnings per share for the quarter, topping analysts' consensus estimates of $0.96 by $0.06. Walgreens Boots Alliance had a return on equity of 18.33% and a net margin of 0.33%. The business had revenue of $34.75 billion for the quarter, compared to analyst estimates of $34.36 billion. During the same quarter in the prior year, the company earned $1.43 earnings per share. The company's revenue was up 2.3% on a year-over-year basis.
WBA has been the topic of a number of research reports. Raymond James restated a "hold" rating on shares of Walgreens Boots Alliance in a research note on Monday, September 7th. Barclays cut their target price on shares of Walgreens Boots Alliance from $45.00 to $40.00 and set an "equal weight" rating on the stock in a report on Thursday, October 8th. Royal Bank of Canada decreased their price target on shares of Walgreens Boots Alliance from $45.00 to $38.00 and set a "sector perform" rating for the company in a research note on Wednesday, September 2nd. Zacks Investment Research cut shares of Walgreens Boots Alliance from a "hold" rating to a "strong sell" rating and set a $42.00 target price for the company. in a report on Friday, July 17th. Finally, Morgan Stanley lowered their price target on Walgreens Boots Alliance from $45.00 to $40.00 and set an "equal weight" rating on the stock in a report on Thursday, September 3rd. Five equities research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the stock. Walgreens Boots Alliance currently has an average rating of "Hold" and a consensus target price of $43.19.
Several hedge funds have recently added to or reduced their stakes in WBA. Northern Oak Wealth Management Inc. grew its stake in Walgreens Boots Alliance by 54.1% in the second quarter. Northern Oak Wealth Management Inc. now owns 715 shares of the pharmacy operator's stock valued at $30,000 after purchasing an additional 251 shares in the last quarter. Campbell Wealth Management acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth $35,000. Cornerstone Advisors Inc. raised its stake in Walgreens Boots Alliance by 47.5% during the second quarter. Cornerstone Advisors Inc. now owns 898 shares of the pharmacy operator's stock worth $38,000 after buying an additional 289 shares during the last quarter. Denali Advisors LLC acquired a new position in Walgreens Boots Alliance in the second quarter valued at $55,000. Finally, Ellevest Inc. boosted its position in Walgreens Boots Alliance by 85.4% during the second quarter. Ellevest Inc. now owns 1,526 shares of the pharmacy operator's stock valued at $65,000 after acquiring an additional 703 shares during the last quarter. Institutional investors and hedge funds own 55.96% of the company's stock.
Shares of WBA stock traded up $0.53 during mid-day trading on Friday, hitting $38.04. 3,875,134 shares of the stock were exchanged, compared to its average volume of 6,579,447. The stock's fifty day simple moving average is $36.27 and its two-hundred day simple moving average is $40.32. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.32 and a current ratio of 0.67. Walgreens Boots Alliance has a 12-month low of $33.88 and a 12-month high of $64.50. The stock has a market capitalization of $32.94 billion, a price-to-earnings ratio of 76.08, a P/E/G ratio of 1.52 and a beta of 0.44.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Day Trading
Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
20 Stocks to Sell Now
Most people know that brokerage rankings are overstated because of pressure from publicly-traded companies. No investor relations person wants to see "hold" and "sell" ratings issued for their stock. In reality, a "buy" rating really means "hold." "Hold" ratings really mean "sell" and "sell" ratings mean get out while you still can.
If Wall Street's top analysts are consistently giving "hold" and "sell" ratings to a stock, you know there's a serious problem. We've compiled a list of the companies that Wall Street's top equities research analysts are consistently giving "hold" and "sell" ratings too. If you own one of these stocks, consider getting out while there's still time.
This slide show lists the 20 companies that have the lowest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
View the "20 Stocks to Sell Now".